Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 5,734 | 1,339 | 584 | 2,254 | 395 |
| Gross Profit | 5,734 | 1,339 | 584 | 2,254 | 395 |
| Operating Expenses | 8,585 | 9,031 | 12,369 | 10,312 | 8,525 |
| Operating Income | -2,851 | -7,691 | -11,785 | -8,058 | -8,131 |
| Interest Expense | 169 | 170 | 197 | 159 | 105 |
| Other Income | 330 | 101 | 189 | 253 | 125 |
| Pre-tax Income | -2,690 | -7,761 | -11,793 | -7,965 | -8,110 |
| Income Tax | 13 | 9 | 10 | 4 | 12 |
| Net Income Continuous | -2,703 | -7,769 | -11,803 | -7,969 | -8,122 |
| Minority Interests | -718 | -601 | N/A | N/A | N/A |
| Net Income | $-1,985 | $-7,169 | $-11,803 | $-7,969 | $-8,122 |
| EPS Basic Total Ops | -0.05 | -0.17 | -0.28 | -0.19 | -0.22 |
| EPS Basic Continuous Ops | -0.06 | -0.18 | -0.25 | -0.19 | -0.22 |
| EPS Diluted Total Ops | -0.05 | -0.17 | -0.28 | -0.19 | -0.22 |
| EPS Diluted Continuous Ops | -0.06 | -0.18 | -0.25 | -0.19 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.08 | -0.26 | -0.20 | -0.22 |
| EBITDA(a) | $-2,385 | $-7,222 | $-11,253 | $-7,594 | $-7,643 |